⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
🇬🇧
💊 Medicine AT May 26, 2026

Valsartan/HCT Sandoz 320 mg/25 mg - Filmtabletten 320 mg/25 mg (Filmtablette)

📷 Wikipedia: Hydrochlorothiazide · Source
Valsartan/HCT Sandoz 320 mg/25 mg - Filmtabletten 320 mg/25 mg (Filmtablette)
📷 Wikipedia: Hydrochlorothiazide · Source
Valsartan/HCT Sandoz 320 mg/25 mg film tablets are subject to a parallel export ban due to manufacturing capacity shortages.
⚠️
Shortage ongoing
HYDROCHLOROTHIAZID is currently in short supply in AT.
📈 Timeline
1 days active so far
May 27, 2026 May 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is a blood-pressure tablet that mixes two medicines: valsartan and hydrochlorothiazide. It comes as a small film-coated pill.

What's happening? The maker cannot make enough of these pills right now. So the packs are out of stock.

Does this affect me? If your doctor gave you this exact pill, you may not be able to get it at the pharmacy.

What should I do? Ask your pharmacist or doctor for another tablet that works the same. Do not stop taking your blood-pressure medicine without advice.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: C09DA03 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-05-26]

First published
May 26, 2026
Last refreshed by us
13 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Valsartan/HCT Sandoz 320 mg/25 mg - Filmtabletten 320 mg/25 mg (Filmtablette). Valsartan/HCT Sandoz 320 mg/25 mg film tablets are subject to a parallel export ban due to manufacturing capacity shortages.
When was this alert issued?
This alert was issued on May 26, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.